BSE filing, NSE: AGARWALEYE. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹511.70
- Market cap
- ₹16,222 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 109.3×Sector 54.5×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Dr. Agarwals Health Care Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%). H1 FY27 revenue ₹1,269 Cr (+28.7%), PAT ₹112 Cr (+50.1%). Strategy is aggressive facility expansion, with 65 FY27E additions.
Dr. Agarwals Health Care Board Meeting Date
Dr. Agarwal's Health Care schedules a board meeting on November 5, 2026 to consider Q2 results. An earnings call follows at 6:30 PM IST that day.
Dr. Agarwals Health Care Merger & Restructuring Worth ₹711.2 Cr
Dr. Agarwals Health Care Limited has completed the merger of Dr. Agarwal's Eye Hospital Limited into itself for a total transaction value of ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care Limited allotted 18,200 equity shares upon the exercise of vested ESOPs. The transaction is valued at approximately ₹0.24 Crore.
- Value
- ₹0.24 Cr
Other financial results announcements
All →CHL Q2 FY27 Results: Turns Profitable, Net Profit ₹1.7 Cr
CHL Ltd reported revenue from operations of ₹37.3 Cr (+17.7% YoY) and net profit of ₹1.7 Cr for Q2 FY27.
- Key figure
- Net profit ₹1.7 Cr
Meta Infotech H1 FY27 Results: Net Profit ₹4.9 Cr, Down 52.9% YoY
Meta Infotech Ltd reported revenue from operations of ₹89.5 Cr (-57.4% YoY) and net profit of ₹4.9 Cr (-52.9% YoY) for H1 FY27.
- Key figure
- Net profit ₹4.9 Cr · -52.9% YoY
Veedol Corporation Q2 FY27 Results: Net Profit ₹49.1 Cr, Up 20.0% YoY
Veedol Corporation Ltd reported revenue from operations of ₹649.2 Cr (+27.5% YoY) and net profit of ₹49.1 Cr (+20.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹49.1 Cr · +20.0% YoY
Speb Adhesives H1 FY27 Results: Net Profit ₹2.5 Cr, Down 32.4% YoY
Speb Adhesives Ltd reported revenue from operations of ₹33.5 Cr (+35.1% YoY) and net profit of ₹2.5 Cr (-32.4% YoY) for H1 FY27.
- Key figure
- Net profit ₹2.5 Cr · -32.4% YoY
Jupiter Infomedia Q2 FY27 Results: Net Loss of ₹2 Cr, Loss Widens
Jupiter Infomedia Ltd reported revenue from operations of ₹0.1 Cr (-88.9% YoY) and a net loss of ₹2 Cr for Q2 FY27.
- Key figure
- Net loss ₹2 Cr
Amrapali Fincap H1 FY27 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY
Amrapali Fincap reported half-year unaudited standalone results to 30 September 2026. Net profit stood at Rs 22.31 lakh.
- Key figure
- Net profit ₹0.2 Cr · +0.0% YoY